Multistage vector (MSV) therapeutics

Joy Wolfram, Haifa Shen, Mauro Ferrari

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

One of the greatest challenges in the field of medicine is obtaining controlled distribution of systemically administered therapeutic agents within the body. Indeed, biological barriers such as physical compartmentalization, pressure gradients, and excretion pathways adversely affect localized delivery of drugs to pathological tissue. The diverse nature of these barriers requires the use of multifunctional drug delivery vehicles that can overcome a wide range of sequential obstacles. In this review, we explore the role of multifunctionality in nanomedicine by primarily focusing on multistage vectors (MSVs). The MSV is an example of a promising therapeutic platform that incorporates several components, including a microparticle, nanoparticles, and small molecules. In particular, these components are activated in a sequential manner in order to successively address transport barriers.

Original languageEnglish (US)
Pages (from-to)406-415
Number of pages10
JournalJournal of Controlled Release
Volume219
DOIs
StatePublished - Dec 10 2015
Externally publishedYes

Fingerprint

Nanomedicine
Pharmaceutical Preparations
Nanoparticles
Medicine
Pressure
Therapeutics

Keywords

  • Biological barriers
  • Cancer therapy
  • Geometrical targeting
  • Porous silicon
  • Transport oncophysics

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Multistage vector (MSV) therapeutics. / Wolfram, Joy; Shen, Haifa; Ferrari, Mauro.

In: Journal of Controlled Release, Vol. 219, 10.12.2015, p. 406-415.

Research output: Contribution to journalArticle

Wolfram, Joy ; Shen, Haifa ; Ferrari, Mauro. / Multistage vector (MSV) therapeutics. In: Journal of Controlled Release. 2015 ; Vol. 219. pp. 406-415.
@article{6b7a9b37a8d649fc8f13606eb0edb0ab,
title = "Multistage vector (MSV) therapeutics",
abstract = "One of the greatest challenges in the field of medicine is obtaining controlled distribution of systemically administered therapeutic agents within the body. Indeed, biological barriers such as physical compartmentalization, pressure gradients, and excretion pathways adversely affect localized delivery of drugs to pathological tissue. The diverse nature of these barriers requires the use of multifunctional drug delivery vehicles that can overcome a wide range of sequential obstacles. In this review, we explore the role of multifunctionality in nanomedicine by primarily focusing on multistage vectors (MSVs). The MSV is an example of a promising therapeutic platform that incorporates several components, including a microparticle, nanoparticles, and small molecules. In particular, these components are activated in a sequential manner in order to successively address transport barriers.",
keywords = "Biological barriers, Cancer therapy, Geometrical targeting, Porous silicon, Transport oncophysics",
author = "Joy Wolfram and Haifa Shen and Mauro Ferrari",
year = "2015",
month = "12",
day = "10",
doi = "10.1016/j.jconrel.2015.08.010",
language = "English (US)",
volume = "219",
pages = "406--415",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",

}

TY - JOUR

T1 - Multistage vector (MSV) therapeutics

AU - Wolfram, Joy

AU - Shen, Haifa

AU - Ferrari, Mauro

PY - 2015/12/10

Y1 - 2015/12/10

N2 - One of the greatest challenges in the field of medicine is obtaining controlled distribution of systemically administered therapeutic agents within the body. Indeed, biological barriers such as physical compartmentalization, pressure gradients, and excretion pathways adversely affect localized delivery of drugs to pathological tissue. The diverse nature of these barriers requires the use of multifunctional drug delivery vehicles that can overcome a wide range of sequential obstacles. In this review, we explore the role of multifunctionality in nanomedicine by primarily focusing on multistage vectors (MSVs). The MSV is an example of a promising therapeutic platform that incorporates several components, including a microparticle, nanoparticles, and small molecules. In particular, these components are activated in a sequential manner in order to successively address transport barriers.

AB - One of the greatest challenges in the field of medicine is obtaining controlled distribution of systemically administered therapeutic agents within the body. Indeed, biological barriers such as physical compartmentalization, pressure gradients, and excretion pathways adversely affect localized delivery of drugs to pathological tissue. The diverse nature of these barriers requires the use of multifunctional drug delivery vehicles that can overcome a wide range of sequential obstacles. In this review, we explore the role of multifunctionality in nanomedicine by primarily focusing on multistage vectors (MSVs). The MSV is an example of a promising therapeutic platform that incorporates several components, including a microparticle, nanoparticles, and small molecules. In particular, these components are activated in a sequential manner in order to successively address transport barriers.

KW - Biological barriers

KW - Cancer therapy

KW - Geometrical targeting

KW - Porous silicon

KW - Transport oncophysics

UR - http://www.scopus.com/inward/record.url?scp=84947485811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947485811&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2015.08.010

DO - 10.1016/j.jconrel.2015.08.010

M3 - Article

C2 - 26264836

AN - SCOPUS:84947485811

VL - 219

SP - 406

EP - 415

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

ER -